Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.
Study Type
OBSERVATIONAL
Enrollment
2,589
Non interventional study.
Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie
Ludwigshafen, RLP, Germany
Chest x-ray
presence of infiltrates
Time frame: throughout study completion, in average 1.5 years
Chest CT
presence of infiltrates
Time frame: throughout study completion, in average 1.5 years
Supportive care - ICU
number of patients with ICU treatment required
Time frame: throughout study completion, in average 1.5 years
Supportive care - oxygen therapy
number of patients with oxygen therapy required
Time frame: throughout study completion, in average 1.5 years
Supportive care - ventilation
number of patients with ventilation required
Time frame: throughout study completion, in average 1.5 years
Medication
number of patients with medication changes
Time frame: throughout study completion, in average 1.5 years
Therapeutic strategies
number of patients with ECMO required
Time frame: throughout study completion, in average 1.5 years
Lab parameters
number of patients with significant changes in lab parameters
Time frame: throughout study completion, in average 1.5 years
Intra-hospital complications
number of patients with complications during hospital stay
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: throughout study completion, in average 1.5 years
Vital status at discharge
vital status at discharge: alive, dead
Time frame: throughout study completion, in average 1.5 years